Syngen Biotech Co.,Ltd. (TPEX:8279)
Taiwan · Delayed Price · Currency is TWD 130.00
+1.00 (0.78%)
At close: Dec 5, 2025
Syngen Biotech Market Cap
Syngen Biotech has a market cap or net worth of 3.52 billion as of December 5, 2025. Its market cap has decreased by -4.41% in one year.
Market Cap
3.52B
Enterprise Value
3.52B
Revenue
2.13B
Ranking
n/a
PE Ratio
12.07
Stock Price
130.00
Market Cap Chart
Since November 2, 2004, Syngen Biotech's market cap has increased from 372.00M to 3.52B, an increase of 847.07%. That is a compound annual growth rate of 11.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 3.52B | 2.36% |
| Dec 30, 2024 | 3.44B | -16.45% |
| Dec 29, 2023 | 4.12B | -6.17% |
| Dec 30, 2022 | 4.39B | 43.36% |
| Dec 30, 2021 | 3.06B | 4.63% |
| Dec 31, 2020 | 2.93B | -8.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 258.22B |
| PharmaEssentia | 191.58B |
| Lotus Pharmaceutical | 78.89B |
| Bora Pharmaceuticals Co., LTD. | 65.31B |
| Lin BioScience | 34.87B |
| Oneness Biotech | 32.96B |
| Lumosa Therapeutics | 32.77B |
| Center Laboratories | 27.88B |